Ultragenyx Pharmaceutical Inc. (RARE) intrinsic value

Price $15.22 on 2026-10-05.

MethodValueMargin of safety
DCF – bear case-$120.87
DCF – base case-$205.51-1450.3%
DCF – bull case-$314.34
Graham Number——

WACC 5.6%, revenue growth 28.1%, FCF margin -30.9%, EPS -$5.82, book value per share -$2.96. 6 valuation runs recorded.

Community analyses of RARE

More valuations

Run your own DCF · How accurate are these valuations?